SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001558370-23-018560
Filing Date
2023-11-09
Accepted
2023-11-09 16:05:23
Documents
15
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A xlo-20221231x10ka.htm   iXBRL 10-K/A 56404
2 EX-31.1 xlo-20221231xex31d1.htm EX-31.1 12789
3 EX-31.2 xlo-20221231xex31d2.htm EX-31.2 12760
  Complete submission text file 0001558370-23-018560.txt   315328

Data Files

Seq Description Document Type Size
4 EX-101.SCH xlo-20221231.xsd EX-101.SCH 4313
5 EX-101.DEF xlo-20221231_def.xml EX-101.DEF 35450
6 EX-101.LAB xlo-20221231_lab.xml EX-101.LAB 25469
7 EX-101.PRE xlo-20221231_pre.xml EX-101.PRE 16480
9 EXTRACTED XBRL INSTANCE DOCUMENT xlo-20221231x10ka_htm.xml XML 8500
Mailing Address 828 WINTER STREET WALTHAM MA 02451
Business Address 828 WINTER STREET WALTHAM MA 02451 617-833-1027
Xilio Therapeutics, Inc. (Filer) CIK: 0001840233 (see all company filings)

IRS No.: 851623397 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-40925 | Film No.: 231392272
SIC: 2834 Pharmaceutical Preparations